Group 1 - The controlling shareholder, Inner Mongolia Jinhe Holdings Co., Ltd., plans to reduce its shareholding by up to 22,563,389 shares, representing 3% of the company's total share capital, from June 10, 2025, to September 9, 2025 [2] - As of August 11, 2025, Jinhe Holdings has already reduced its holdings by 5,065,000 shares, bringing its total shareholding to 273,679,052 shares, which is 36.3880% of the company's total share capital after excluding shares in the repurchase account [2][6] - The total share capital for calculation purposes is 752,112,988 shares, after excluding 19,521,410 shares in the company's repurchase account [2] Group 2 - The company has recently obtained an invention patent and a design patent from the National Intellectual Property Administration [5] - The invention patent relates to a microbial fermentation plant with a circular distribution of fermentation tanks, optimizing space utilization and energy consumption in the company's sixth-phase fermentation workshop [6] - The design patent protects the visual appearance of the microbial fermentation plant, enhancing the company's industrial architectural image [6][7]

Group 1 - The company Jinhe Biology (SZ 002688, closing price: 7.69 yuan) announced on August 12 that it has recently obtained invention and design patent certificates from the National Intellectual Property Administration for a patent titled "Microbial Fermentation Plant with Circumferential Distribution of Tank Body" [2] - For the first half of 2025, Jinhe Biology's revenue composition is as follows: veterinary chemical drugs account for 61.83%, agricultural product processing accounts for 19.76%, veterinary biological products account for 11.12%, environmental protection business accounts for 4.97%, and others account for 2.15% [2]